Mutations in all four Notch receptors have been identified in HNSCC, with NOTCH1 mutations being the most prevalent (17–20%), followed by NOTCH2 (7–9%), NOTCH3 (5%), and NOTCH4 (2–3%). Here, NOTCH3 is linked to head and neck squamous cell carcinoma.